The work of the Centre is being taken forward by the Health Education England Genomics Education Programme. To find out more about the programme click here.


Section menu

MCADD (Medium Chain Acyl-CoA Dehydrogenase Deficiency)

Clinical features: Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) is an inherited metabolic condition that affects the individual’s ability to metabolise medium-chain fatty acids. This means that if the period of ‘starvation’ between meals is extended unduly the individual is at risk of experiencing metabolic crisis which may result in coma and death. This condition can be managed through diet, and individuals with this condition survive into adulthood with a normal life expectancy.

Incidence: MCADD occurs in one in 10,000 births.

Inheritance: This is an autosomal recessive condition which results from an alteration in the ACADM gene.

For more information about the identification and treatment of infants, children and adults with MCADD please take a look at the following e-learning resources:

Flash Media

Dietary treatment of MCADD – an inherited metabolic disorder

This e-learning resource, designed for dieticians, explains MCADD, an inherited metabolic condition.

Flash Media

Identification of pregnancies at risk of MCADD and post natal care of ‘at risk’ infants

This e-learning resource, designed for midwives, explains MCADD, an inherited metabolic condition. Doctors, health visitors and paediatric nurses may also find the resource useful.